In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 3rd, 2005 | 16 | Yes |
Popular Name: 3-ISOBUTYL-1-METHYLXANTHINE 3-ISOBUTYL-1-METHYLXANTHINE
Find On: PubMed — Wikipedia — Google
CAS Number: 28822-58-4
1H-purine-2,6-dione, 3,9-dihydro-1-methyl-3-(2-methylpropyl)-
28822-58-4; 3-Isobutyl-1-methyxanthine; C13708; IBMX
3-isobuthyl-1-methylxanthine; 3-isobutyl-1-methylxanthine; CPD-5461
3-Isobutyl-1-methyl-1H-purine-2,6(3H,7H)-dione
3-isobutyl-1-methyl-3,9-dihydro-1H-purine-2,6-dione
3-Isobutyl-1-methyl-3,9-dihydro-purine-2,6-dione
3-isobutyl-1-methyl-7H-xanthine
3-isobutyl-1-methyl-9H-xanthine
3-ISOBUTYL-1-METHYLXANTHINE (IBMX)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.12 | 5.25 | -10.93 | 1 | 6 | 0 | 73 | 222.248 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Antidepressant | ZereneX Building Blocks |
MP | 199 - 201 °C | Fluorochem |
Mp [°C] | 200 - 203 | Acros Organics |
ALOGPS_SOLUBILITY | 5.44e+00 g/l | DrugBank-experimental |
Purity | >99% | Fluorochem |
biological_use | Antidepressant | IBScreen Bioactives IBScreen Bioactives |
Patent Database Links | EP1283056; EP1510222; US2005148067; US2007185213; US2007232698 | ChEBI |
H phrase | H302: Harmful if swallowed | Acros Organics |
P phrase | P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell | Acros Organics |
UniProt Database Links | PDE10_HUMAN; PDE10_RAT; PDE11_HUMAN; PDE11_MOUSE; PDE11_RAT; PDE11_TAKRU; PDE2_DICDI; PDE3_DICDI; PDE4_DICDI; PDE5A_CANFA; PDE7B_HUMAN; PDE7B_MOUSE; PDE8A_HUMAN; PDE8A_MOUSE; PDE8B_HUMAN; PDE8B_MOUSE; PRUNE_BOVIN; PRUNE_HUMAN; PRUNE_MOUSE; PRUNE_RAT; U76C | ChEBI |
UniProt Database Links | PDE11_HUMAN; PDE11_MOUSE; PDE11_RAT; PDE11_TAKRU; PDE2_DICDI; PDE3_DICDI; PDE4_DICDI; PDE5A_CANFA; U76C1_ARATH; U76C2_ARATH | ChEBI |
mechanism | Phosphodiesterase inhibitor | IBScreen Bioactives |
Therapy | Potent phosphodiesterase inhibitor; more active than theophylline at adenosine receptors | SMDC MicroSource |
biological_use | Psychostimulant | IBScreen Bioactives |
R phrase | R22: Harmful if swallowed. | Acros Organics |
S phrase | S24/25: Avoid contact with skin and eyes. | Acros Organics |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA1R-2-E | Adenosine A1 Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 5900 | 0.46 | Binding ≤ 10μM |
AA2AR-1-E | Adenosine A2a Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 8000 | 0.45 | Binding ≤ 10μM |
AA2BR-1-E | Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9100 | 0.44 | Binding ≤ 10μM |
AA3R-2-E | Adenosine Receptor A3 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 800 | 0.53 | Binding ≤ 10μM |
PDE1A-1-E | Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.48 | Binding ≤ 10μM |
PDE1B-1-E | Phosphodiesterase 1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.48 | Binding ≤ 10μM |
PDE1C-1-E | Phosphodiesterase 1C (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.48 | Binding ≤ 10μM |
PDE3A-1-E | Phosphodiesterase 3A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6900 | 0.45 | Binding ≤ 10μM |
PDE3B-1-E | Phosphodiesterase 3B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6900 | 0.45 | Binding ≤ 10μM |
PDE4A-3-E | Phosphodiesterase 4A (cluster #3 Of 3), Eukaryotic | Eukaryotes | 6900 | 0.45 | Binding ≤ 10μM |
PDE4B-2-E | Phosphodiesterase 4B (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6900 | 0.45 | Binding ≤ 10μM |
PDE4C-2-E | Phosphodiesterase 4C (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6900 | 0.45 | Binding ≤ 10μM |
PDE4D-2-E | Phosphodiesterase 4D (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6900 | 0.45 | Binding ≤ 10μM |
PDE5A-1-E | Phosphodiesterase 5A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3020 | 0.48 | Binding ≤ 10μM |
PDE7A-1-E | Phosphodiesterase 7A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.47 | Binding ≤ 10μM |
PDE7B-1-E | Phosphodiesterase 7B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.47 | Binding ≤ 10μM |
SCN1A-1-E | Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.50 | Binding ≤ 10μM |
SCN2A-2-E | Sodium Channel Protein Type II Alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.50 | Binding ≤ 10μM |
SCN3A-1-E | Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.50 | Binding ≤ 10μM |
SCN8A-1-E | Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.50 | Binding ≤ 10μM |
AA2AR-1-E | Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8000 | 0.45 | Functional ≤ 10μM |
AA2BR-1-E | Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6300 | 0.46 | Functional ≤ 10μM |
PDE1B-2-E | Phosphodiesterase 1B (cluster #2 Of 2), Eukaryotic | Eukaryotes | 100 | 0.61 | Functional ≤ 10μM |
PDE1C-2-E | Phosphodiesterase 1C (cluster #2 Of 2), Eukaryotic | Eukaryotes | 100 | 0.61 | Functional ≤ 10μM |
Q9EPR9-1-E | Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.61 | Functional ≤ 10μM |
Z50597-2-O | Rattus Norvegicus (cluster #2 Of 5), Other | Other | 800 | 0.53 | Binding ≤ 10μM |
Z50588-1-O | Canis Familiaris (cluster #1 Of 7), Other | Other | 5500 | 0.46 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 3500 | 0.48 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA1R_RAT | P25099 | Adenosine A1 Receptor, Rat | 50 | 0.64 | Binding ≤ 1μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 50 | 0.64 | Binding ≤ 1μM |
AA2BR_RAT | P29276 | Adenosine A2b Receptor, Rat | 50 | 0.64 | Binding ≤ 1μM |
AA3R_RAT | P28647 | Adenosine A3 Receptor, Rat | 50 | 0.64 | Binding ≤ 1μM |
Z50597 | Z50597 | Rattus Norvegicus | 50 | 0.64 | Binding ≤ 1μM |
AA1R_HUMAN | P30542 | Adenosine A1 Receptor, Human | 5900 | 0.46 | Binding ≤ 10μM |
AA1R_BOVIN | P28190 | Adenosine A1 Receptor, Bovin | 7000 | 0.45 | Binding ≤ 10μM |
AA1R_RAT | P25099 | Adenosine A1 Receptor, Rat | 2000 | 0.50 | Binding ≤ 10μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 2000 | 0.50 | Binding ≤ 10μM |
AA2AR_CAVPO | P46616 | Adenosine A2a Receptor, Guinea Pig | 8000 | 0.45 | Binding ≤ 10μM |
AA2BR_RAT | P29276 | Adenosine A2b Receptor, Rat | 2000 | 0.50 | Binding ≤ 10μM |
AA3R_RAT | P28647 | Adenosine A3 Receptor, Rat | 2000 | 0.50 | Binding ≤ 10μM |
PDE1A_BOVIN | P14100 | Phosphodiesterase 1A, Bovin | 1800 | 0.50 | Binding ≤ 10μM |
PDE1A_HUMAN | P54750 | Phosphodiesterase 1A, Human | 3400 | 0.48 | Binding ≤ 10μM |
PDE1B_HUMAN | Q01064 | Phosphodiesterase 1B, Human | 3400 | 0.48 | Binding ≤ 10μM |
PDE1B_BOVIN | Q01061 | Phosphodiesterase 1B, Bovin | 1800 | 0.50 | Binding ≤ 10μM |
PDE1C_HUMAN | Q14123 | Phosphodiesterase 1C, Human | 3400 | 0.48 | Binding ≤ 10μM |
PDE3A_HUMAN | Q14432 | Phosphodiesterase 3A, Human | 6900 | 0.45 | Binding ≤ 10μM |
PDE3B_HUMAN | Q13370 | Phosphodiesterase 3B, Human | 6900 | 0.45 | Binding ≤ 10μM |
PDE4A_HUMAN | P27815 | Phosphodiesterase 4A, Human | 6900 | 0.45 | Binding ≤ 10μM |
PDE4B_HUMAN | Q07343 | Phosphodiesterase 4B, Human | 6900 | 0.45 | Binding ≤ 10μM |
PDE4C_HUMAN | Q08493 | Phosphodiesterase 4C, Human | 6900 | 0.45 | Binding ≤ 10μM |
PDE4D_HUMAN | Q08499 | Phosphodiesterase 4D, Human | 6900 | 0.45 | Binding ≤ 10μM |
PDE5A_HUMAN | O76074 | Phosphodiesterase 5A, Human | 3020 | 0.48 | Binding ≤ 10μM |
PDE7A_HUMAN | Q13946 | Phosphodiesterase 7A, Human | 4000 | 0.47 | Binding ≤ 10μM |
PDE7B_HUMAN | Q9NP56 | Phosphodiesterase 7B, Human | 4000 | 0.47 | Binding ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 2000 | 0.50 | Binding ≤ 10μM |
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 1800 | 0.50 | Binding ≤ 10μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 1800 | 0.50 | Binding ≤ 10μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 1800 | 0.50 | Binding ≤ 10μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 1800 | 0.50 | Binding ≤ 10μM |
AA2AR_CAVPO | P46616 | Adenosine A2a Receptor, Guinea Pig | 8000 | 0.45 | Functional ≤ 10μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 6300 | 0.46 | Functional ≤ 10μM |
AA2BR_RAT | P29276 | Adenosine A2b Receptor, Rat | 6300 | 0.46 | Functional ≤ 10μM |
Z50588 | Z50588 | Canis Familiaris | 1000 | 0.53 | Functional ≤ 10μM |
Q9EPR9_RAT | Q9EPR9 | Phosphodiesterase 1A, Rat | 100 | 0.61 | Functional ≤ 10μM |
PDE1B_RAT | Q01066 | Phosphodiesterase 1B, Rat | 100 | 0.61 | Functional ≤ 10μM |
PDE1C_RAT | Q63421 | Phosphodiesterase 1C, Rat | 100 | 0.61 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 100 | 0.61 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenosine P1 receptors | |
Cam-PDE 1 activation | |
cGMP effects | |
DARPP-32 events | |
G alpha (i) signalling events | |
G alpha (s) signalling events | |
Interaction between L1 and Ankyrins | |
NGF-independant TRKA activation | |
PDE3B signalling |